Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Appoints Former Nestlé Canada President and CEO, Shelley Martin, to Board of Directors

GlobeNewswire June 22, 2020

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

GlobeNewswire June 22, 2020

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 24th

Canada NewsWire June 22, 2020

MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence Sales

GlobeNewswire June 19, 2020

MediPharm Labs Announces Participation at Upcoming Conferences

GlobeNewswire June 19, 2020

MediPharm Labs Reports First Quarter 2020 Results, Clears Path for International Growth

GlobeNewswire June 18, 2020

MediPharm Labs Sets Date to Release First Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire June 11, 2020

MediPharm Labs Closes $37.8 Million Private Placement

GlobeNewswire June 8, 2020

MediPharm Labs Accelerates Growth of Pharma-Quality Product Portfolio With Launch of its New CBD50 Plus Formula

GlobeNewswire June 4, 2020

MediPharm Labs Announces Participation at Upcoming Conferences

GlobeNewswire May 29, 2020

MediPharm Labs and Argentia Gold to Bring Premium Cannabis-Infused Products to Atlantic Canada

GlobeNewswire May 27, 2020

REPEAT - MediPharm Labs and Ace Valley Deliver Innovative Vapes - Now Available in Several Markets Across Canada

GlobeNewswire May 26, 2020

MediPharm Labs and Ace Valley Deliver Innovative Vapes - Now Available in Several Markets Across Canada

GlobeNewswire May 25, 2020

MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray's Therismos

GlobeNewswire May 15, 2020

MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.

GlobeNewswire May 14, 2020

Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs

Canada NewsWire May 14, 2020

MediPharm Labs to File First Quarter Financial Statements and MD&A in June 2020, Provides Q1 Update

GlobeNewswire May 14, 2020

MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements

GlobeNewswire May 7, 2020

REPEAT - Champignon Appoints Pat McCutcheon to Board of Directors

GlobeNewswire May 6, 2020

Champignon Appoints Pat McCutcheon to Board of Directors

GlobeNewswire May 6, 2020